Yes, ncRNAs hold potential as biomarkers for early diagnosis and prognosis of pediatric diseases. For example, specific miRNAs can be detected in blood or urine, offering a non-invasive method to diagnose conditions like Wilms' tumor and congenital heart disease. This ability to serve as biomarkers makes ncRNAs valuable in clinical settings.
